Huijun Yue

Huijun Yue

Auto-generated profile, based on publicly available information

Huijun Yue

Otorhinolaryngology Hospital, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in Sleep Medicine Reviews
Verified
Journal Article
Open access
HYHuijun Yue
Huijun Yue
ZCZhuqi Chen
Zhuqi Chen
WGWenbin Guo
Wenbin Guo
LSLin Sun
Lin Sun
YDYidan Dai
Yidan Dai
WLWenbin Lei
Wenbin Lei
Over the past few decades, researchers have attempted to simplify and accelerate the process of sleep stage classification through various approaches; however, only a few such approaches have gained widespread acceptance. Artificial intelligence technology, particularly deep learning, is promising for earning the trust of the sleep medicine community in automated sleep-staging systems, thus facilitating its application in clinical practice and integration into daily life. We aimed to comprehensively review the latest methods that are applying deep learning for enhancing sleep staging efficiency and accuracy. Starting from the requisite "data" for constructing deep learning algorithms, we elucidated the current landscape of this domain and summarized the fundamental modeling process, encompassing signal selection, data pre-processing, model architecture, classification tasks, and performance metrics. Furthermore, we reviewed the applications of automated sleep staging in scenarios such as sleep-disorder screening, diagnostic procedures, and health monitoring and management. Finally, we conducted an in-depth analysis and discussion of the challenges and future in intelligent sleep staging, particularly focusing on large-scale sleep datasets, interdisciplinary collaborations, and human-computer interactions.

1 March 2021 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
HYHuijun Yue
Huijun Yue
YLYu Lin
Yu Lin
YWYitao Wu
Yitao Wu
YWYongquan Wang
Yongquan Wang
YLYun Li
Yun Li
WLWenbin Lei
Wenbin Lei
Purpose: This study evaluated a novel approach for diagnosis and classification of obstructive sleep apnea (OSA), called Obstructive Sleep Apnea Smart System (OSASS), using residual networks and single-channel nasal pressure airflow signals. Methods: Data were collected from the sleep center of the First Affiliated Hospital, Sun Yat-sen University, and the Integrative Department of Guangdong Province Traditional Chinese Medical Hospital. We developed a new model called the multi-resolution residual network (Mr-ResNet) based on a residual network to detect nasal pressure airflow signals recorded by polysomnography (PSG) automatically. The performance of the model was assessed by its sensitivity, specificity, accuracy, and F1-score. We built OSASS based on Mr-ResNet to estimate the apnea‒hypopnea index (AHI) and to classify the severity of OSA, and compared the agreement between OSASS output and the registered polysomnographic technologist (RPSGT) score, assessed by two technologists. Results: In the primary test set, the sensitivity, specificity, accuracy, and F1-score of Mr-ResNet were 90.8%, 90.5%, 91.2%, and 90.5%, respectively. In the independent test set, the Spearman correlation for AHI between OSASS and the RPSGT score determined by two technologists was 0.94 (p < 0.001) and 0.96 (p < 0.001), respectively. Cohen’s Kappa scores for classification between OSASS and the two technologists’ scores were 0.81 and 0.84, respectively. Conclusion: Our results indicated that OSASS can automatically diagnose and classify OSA using signals from a single-channel nasal pressure airflow, which is consistent with polysomnographic technologists’ findings. Thus, OSASS holds promise for clinical application.

30 March 2020 in RNA Biology
Verified
Journal Article
Closed access
KLKexing Lyu
Kexing Lyu
YLYun Li
Yun Li
YXYang Xu
Yang Xu
HYHuijun Yue
Huijun Yue
YWYihui Wen
Yihui Wen
WLWenbin Lei
Wenbin Lei
Accumulating evidence indicates that lncRNAs can interact with miRNAs to regulate target mRNAs through competitive interactions. However, this mechanism remains largely unexplored in laryngeal squamous cell carcinoma (LSCC). In this study, transcriptome-wide RNA sequencing was performed on 3 pairs of LSCC tissues and adjacent normal tissues to investigate the expression profiles of lncRNAs, miRNAs and mRNAs, with differential expression of 171 lncRNAs, 36 miRNAs and 1709 mRNAs detected. Seven lncRNAs, eight mRNAs and three miRNAs were identified to be dysregulated in patients’ tissues by using qRT-PCR. GO and KEGG pathway enrichment analyses were performed to elucidate the potential functions of these differentially expressed genes in LSCC. Subsequently, a ceRNA (lncRNA-miRNA-mRNA) network including 4631 ceRNA pairs was constructed based on predicted miRNAs shared by lncRNAs and mRNAs. Cis- and transregulatory lncRNAs were analysed by bioinformatics-based methods. Importantly, mRNA-related ceRNA networks (mRCNs) were further obtained based on potential cancer-related coding genes. Coexpression between lncRNAs and downstream mRNAs was used as a criterion for the validation of mRCNs, with the ZNF561-AS1-miR217-WNT5A and SATB1-AS1-miR1299-SAV1/CCNG2/SH3 KBP1/JADE1/HIPK2 ceRNA regulatory interactions determined, followed by experimental validation after siRNA transfection. Moreover, ceRNA activity analysis revealed that different activities of ceRNA modules existing in specific pathological environments may contribute to the tumorigenesis of LSCC. Consistently, both downregulated SATB1-AS1 and ZNF561-AS1 significantly promoted laryngeal cancer cell migration and invasion, indicating their important roles in LSCC via a ceRNA regulatory mechanism. Taken together, the results of this investigation uncovered and systemically characterized a lncRNA-related ceRNA regulatory network that may be valuable for the diagnosis and treatment of LSCC.

16 February 2024 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
DPDandan Peng
Dandan Peng
HYHuijun Yue
Huijun Yue
WTWenjun Tan
Wenjun Tan
WLWenbin Lei
Wenbin Lei
GCGuozhu Chen
Guozhu Chen
YZYanchun Zhang
Yanchun Zhang

10 October 2025 in Sleep Health
Verified
Journal Article
Open access
LSLin Sun
Lin Sun
WWWei Wang
Wei Wang
YWYiming Wang
Yiming Wang
WGWenbin Guo
Wenbin Guo
ZCZhuqi Chen
Zhuqi Chen
HYHuijun Yue
Huijun Yue
To evaluate the clinical diagnostic efficiency of the low-load sleep monitor Tsingray Sleep Respiratory Monitoring System QSA600 (Tsingray QSA600) against type 1 polysomnography (PSG) for obstructive sleep apnea (OSA). This diagnostic study consecutively recruited 200 participants who underwent simultaneous overnight monitoring with both PSG and Tsingray QSA600 at the sleep center. The performance of Tsingray QSA600 was assessed against PSG considering 3 aspects: overnight sleep respiratory parameters, event-level analysis (apnea-hypopnea and oxygen desaturation), and sleep staging. Accuracy, sensitivity, specificity, intra-class correlation coefficient, Cohen's κ, and Bland-Altman analysis were evaluated. The sensitivity and specificity for predicting the apnea-hypopnea index (AHI) in patients with mild, moderate, and severe OSA were 95.5%, 97.7%, and 96.5% and 77.6%, 86.8%, and 93.0%, respectively, with a mean absolute error of 3.573 events per hour. The intra-class correlation coefficient between the reference and predicted AHI was 0.965. The sensitivity and specificity were 83.4% and 94.3% for predicting individual apnea-hypopnea, and 71.4% and 92.0% for predicting oxygen desaturation events, respectively. The accuracy of predicting sleep stages (nonrapid eye movement, rapid eye movement, and wakefulness) was 80.3% (Cohen's κ: 0.614). Tsingray QSA600 demonstrated significant practical application value owing to its good diagnostic efficacy, low-load, and accessible capability as a screening device for OSA and sleep tracking in patients with OSA. However, its limited accuracy in diagnosing mild OSA and interpreting sleep stages precludes replacing gold standard PSG. Validation study of a new type of sleep monitoring device for diagnosis of sleep-disordered breathing. www.chictr.org.cn (Identifier: ChiCTR2400093764).